UK - Watson Wyatt has lost out to Hewitt Associates on the back of pharmaceuticals giant GlaxoSmithKline's (GSK) decision to consolidate its existing UK defined benefit pension arrangements, with Hewitt as the sole investment consultant.
Since the merger of GlaxoWellcome and SmithKline Beecham in 2000, both sets of legacy arrangements continued to operate separately, with Watson Wyatt advising the GlaxoWellcome pension fund and Hew...
To continue reading this article...
Join Professional Pensions
- Unlimited access to real-time news, analysis and opinion from the industry
- Receive our in-depth monthly magazine in either print or digital format
- Access our Sustainable Investment Hub covering news and opinion from thought leaders in the ESG space
- Receive important and breaking news stories selected by the Editors in our daily newsletter
- Hear from industry experts and other forward-thinking leaders
- Receive a monthly members-only newsletter with exclusive opinion pieces from leading industry experts and a feature from the magazine in advance of its release date